Clearside Biomedical Inc (NASDAQ:CLSD)

1.41
BATS BZX Real-Time Price
As of Oct 29
 0.00 / 0.00%
Today’s Change
0.96
Today|||52-Week Range
4.13
-51.38%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$60.7M

Company Description

Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.

Contact Information

Clearside Biomedical, Inc.
900 North Point parkway
Alpharetta Georgia 30005
P:(678) 270-3631
Investor Relations:
(678) 430-8206

Employees

Shareholders

Mutual fund holders9.86%
Individual stakeholders29.59%
Other institutional19.96%

Top Executives

George M. LasezkayPresident, Chief Executive Officer & Director
Charles A. DeignanSecretary, Chief Financial & Accounting Officer
Thomas A. CiullaChief Medical Officer
Leslie B. ZacksChief Compliance Officer & General Counsel
Rafael V. AndinoVice President-Engineering & Manufacturing